Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Dissociative identity as a continuum from healthy mind to psychiatric disorders: Epistemological and neurophenomenological implications approached through hypnosis.

Facco E, Mendozzi L, Bona A, Motta A, Garegnani M, Costantini I, Dipasquale O, Cecconi P, Menotti R, Coscioli E, Lipari S.

Med Hypotheses. 2019 Sep;130:109274. doi: 10.1016/j.mehy.2019.109274. Epub 2019 Jun 11.

PMID:
31383343
2.

Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis.

Pelizzari L, Laganà MM, Baglio F, Bergsland N, Cecconi P, Viotti S, Pugnetti L, Nemni R, Baselli G, Clerici M, Mendozzi L.

Brain Imaging Behav. 2019 Jun 7. doi: 10.1007/s11682-019-00132-5. [Epub ahead of print]

PMID:
31175576
3.

A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.

Piancone F, Saresella M, Marventano I, La Rosa F, Caputo D, Mendozzi L, Rovaris M, Clerici M.

J Immunol. 2019 Jul 1;203(1):76-83. doi: 10.4049/jimmunol.1801625. Epub 2019 May 29.

PMID:
31142599
4.

Integrated telerehabilitation approach in multiple sclerosis: A systematic review and meta-analysis.

Di Tella S, Pagliari C, Blasi V, Mendozzi L, Rovaris M, Baglio F.

J Telemed Telecare. 2019 May 27:1357633X19850381. doi: 10.1177/1357633X19850381. [Epub ahead of print] No abstract available.

PMID:
31132909
5.

An ecological measure to screen executive functioning in MS: the Picture Interpretation Test (PIT) 360°.

Realdon O, Serino S, Savazzi F, Rossetto F, Cipresso P, Parsons TD, Cappellini G, Mantovani F, Mendozzi L, Nemni R, Riva G, Baglio F.

Sci Rep. 2019 Apr 5;9(1):5690. doi: 10.1038/s41598-019-42201-1.

6.

Longitudinal associations between mindfulness and well-being in people with multiple sclerosis.

Pagnini F, Cavalera C, Rovaris M, Mendozzi L, Molinari E, Phillips D, Langer E.

Int J Clin Health Psychol. 2019 Jan;19(1):22-30. doi: 10.1016/j.ijchp.2018.11.003. Epub 2018 Dec 5.

7.

Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration.

Laganá MM, Mendozzi L, Pelizzari L, Bergsland NP, Pugnetti L, Cecconi P, Baselli G, Clerici M, Nemni R, Baglio F.

Curr Neurovasc Res. 2018;15(4):282-291. doi: 10.2174/1567202616666181123164235.

PMID:
30468125
8.

Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis.

Piancone F, Saresella M, Marventano I, La Rosa F, Santangelo MA, Caputo D, Mendozzi L, Rovaris M, Clerici M.

Front Immunol. 2018 May 4;9:983. doi: 10.3389/fimmu.2018.00983. eCollection 2018.

9.

Online meditation training for people with multiple sclerosis: A randomized controlled trial.

Cavalera C, Rovaris M, Mendozzi L, Pugnetti L, Garegnani M, Castelnuovo G, Molinari E, Pagnini F.

Mult Scler. 2019 Apr;25(4):610-617. doi: 10.1177/1352458518761187. Epub 2018 Feb 27.

PMID:
29485319
10.

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study.

Saresella M, Mendozzi L, Rossi V, Mazzali F, Piancone F, LaRosa F, Marventano I, Caputo D, Felis GE, Clerici M.

Front Immunol. 2017 Oct 25;8:1391. doi: 10.3389/fimmu.2017.01391. eCollection 2017.

11.

Sympathetic skin response in multiple sclerosis: a meta-analysis of case-control studies.

Margaritella N, Mendozzi L, Garegnani M, Gilardi E, Nemni R, Pugnetti L.

Neurol Sci. 2018 Jan;39(1):45-52. doi: 10.1007/s10072-017-3111-6. Epub 2017 Sep 29. Review.

12.

Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients.

Bergsland N, Agostini S, Laganà MM, Mancuso R, Mendozzi L, Tavazzi E, Cecconi P, Clerici M, Baglio F.

Neuroreport. 2017 Aug 2;28(11):645-648. doi: 10.1097/WNR.0000000000000804.

PMID:
28509815
13.

Hypnotism as a Function of Trance State Effects, Expectancy, and Suggestibility: An Italian Replication.

Pekala RJ, Baglio F, Cabinio M, Lipari S, Baglio G, Mendozzi L, Cecconi P, Pugnetti L, Sciaky R.

Int J Clin Exp Hypn. 2017 Apr-Jun;65(2):210-240. doi: 10.1080/00207144.2017.1276365.

PMID:
28230463
14.

B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.

Piancone F, Saresella M, Marventano I, La Rosa F, Zoppis M, Agostini S, Longhi R, Caputo D, Mendozzi L, Rovaris M, Clerici M.

Sci Rep. 2016 Jul 14;6:29699. doi: 10.1038/srep29699.

15.

A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.

Cavalera C, Pagnini F, Rovaris M, Mendozzi L, Pugnetti L, Garegnani M, Molinari E.

Trials. 2016 Jan 4;17:4. doi: 10.1186/s13063-015-1136-9.

16.

Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Gironi M, Borgiani B, Mariani E, Cursano C, Mendozzi L, Cavarretta R, Saresella M, Clerici M, Comi G, Rovaris M, Furlan R.

J Immunol Res. 2014;2014:961863. doi: 10.1155/2014/961863. Epub 2014 Mar 26.

17.

The EP-score to assess treatment efficacy in RRMS patients: a preliminary study.

Margaritella N, Mendozzi L, Garegnani M, Nemni R, Gilardi E, Pugnetti L.

Int J Neurosci. 2015 Jan;125(1):38-42. doi: 10.3109/00207454.2014.904305. Epub 2014 May 8.

PMID:
24628579
18.

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M.

Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.

19.

Commentary on "Altered and asymmetric default mode network activity in a "hypnotic virtuoso": an fMRI and EEG study"--reply.

Lipari S, Baglio F, Griffanti L, Mendozzi L, Garegnani M, Motta A, Cecconi P, Pugnetti L.

Conscious Cogn. 2013 Jun;22(2):385-7. doi: 10.1016/j.concog.2013.01.005. Epub 2013 Feb 14. No abstract available.

PMID:
23416537
20.

The evoked potentials score improves the identification of benign MS without cognitive impairment.

Margaritella N, Mendozzi L, Tronci F, Colicino E, Garegnani M, Nemni R, Gilardi E, Pugnetti L.

Eur J Neurol. 2013 Oct;20(10):1423-5. doi: 10.1111/ene.12071. Epub 2013 Jan 7.

PMID:
23293907
21.

Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?

Margaritella N, Mendozzi L, Garegnani M, Nemni R, Colicino E, Gilardi E, Pugnetti L.

BMC Neurol. 2012 Aug 22;12:80. doi: 10.1186/1471-2377-12-80.

22.

Altered and asymmetric default mode network activity in a "hypnotic virtuoso": an fMRI and EEG study.

Lipari S, Baglio F, Griffanti L, Mendozzi L, Garegnani M, Motta A, Cecconi P, Pugnetti L.

Conscious Cogn. 2012 Mar;21(1):393-400. doi: 10.1016/j.concog.2011.11.006. Epub 2011 Dec 16.

PMID:
22178091
23.

Effects of elastic compression on hypomobility edema and fibrinolysis activation in multiple sclerosis.

Arpaia G, Bavera PM, Caputo D, Mendozzi L, Cavarretta R, Rovaris M, Agus GB, Belcaro G, Milani M, Ippolito E, Spezzigu G, Cimminiello C.

Panminerva Med. 2011 Sep;53(3 Suppl 1):71-4.

PMID:
22108480
24.

Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis.

Margaritella N, Mendozzi L, Garegnani M, Colicino E, Gilardi E, Deleonardis L, Tronci F, Pugnetti L.

Neurol Sci. 2012 Aug;33(4):887-92. doi: 10.1007/s10072-011-0862-3. Epub 2011 Nov 27.

PMID:
22120189
25.

Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study.

Bastianello S, Romani A, Viselner G, Tibaldi EC, Giugni E, Altieri M, Cecconi P, Mendozzi L, Farina M, Mariani D, Galassi A, Quattrini C, Mancini M, Bresciamorra V, Lagace A, McDonald S, Bono G, Bergamaschi R.

BMC Neurol. 2011 Oct 26;11:132. doi: 10.1186/1471-2377-11-132.

26.

Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.

Mendozzi L, Tronci F, Garegnani M, Pugnetti L.

Mult Scler. 2010 Feb;16(2):238-47. doi: 10.1177/1352458509354551. Epub 2009 Dec 22.

PMID:
20028705
27.

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.

Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, Caputo D, Borelli M, Clerici M.

J Immunol. 2009 Oct 15;183(8):4984-93. doi: 10.4049/jimmunol.0901038. Epub 2009 Sep 30.

28.

Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study.

Arpaia G, Bavera PM, Caputo D, Mendozzi L, Cavarretta R, Agus GB, Milani M, Ippolito E, Cimminiello C.

Thromb Res. 2010 Apr;125(4):315-7. doi: 10.1016/j.thromres.2009.06.023. Epub 2009 Jul 29.

PMID:
19640570
29.

Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study.

Giordano A, Pucci E, Naldi P, Mendozzi L, Milanese C, Tronci F, Leone M, Mascoli N, La Mantia L, Giuliani G, Solari A.

J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):1023-8. doi: 10.1136/jnnp.2008.171181. Epub 2009 May 13.

PMID:
19443471
30.

CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.

Saresella M, Marventano I, Longhi R, Lissoni F, Trabattoni D, Mendozzi L, Caputo D, Clerici M.

FASEB J. 2008 Oct;22(10):3500-8. doi: 10.1096/fj.08-110650. Epub 2008 Jun 27.

PMID:
18587005
31.

A shortened version of PASAT-3 is feasible.

Solari A, Motta A, Radice D, Mendozzi L.

Mult Scler. 2007 Sep;13(8):1020-5. Epub 2007 Jul 10.

PMID:
17623728
32.

Procedure for the quantitative evaluation of motor disturbances in cerebellar ataxic patients.

Ferrarin M, Gironi M, Mendozzi L, Nemni R, Mazzoleni P, Rabuffetti M.

Med Biol Eng Comput. 2005 May;43(3):349-56.

PMID:
16035223
33.

Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial.

Solari A, Motta A, Mendozzi L, Pucci E, Forni M, Mancardi G, Pozzilli C; CRIMS Trial.

J Neurol Sci. 2004 Jul 15;222(1-2):99-104. Erratum in: J Neurol Sci. 2004 Sep 15;224(1-2):113.

PMID:
15240203
34.

Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis.

Solari A, Motta A, Mendozzi L, Aridon P, Bergamaschi R, Ghezzi A, Mancardi GL, Milanese C, Montanari E, Pucci E.

Neurol Sci. 2004 Feb;24(6):375-83.

PMID:
14767682
35.

Falls in the elderly: the development of a risk questionnaire and posturographic findings.

Alpini D, Kohen-Ratz R, Braun R, Burstin A, Tesio L, Pugnetti L, Mendozzi L, Sambataro G, Cesarani A, Giuliano DA.

Int Tinnitus J. 2001;7(2):105-8.

PMID:
14689646
36.

Comparison of two brief neuropsychological batteries in people with multiple sclerosis.

Solari A, Mancuso L, Motta A, Mendozzi L, Serrati C.

Mult Scler. 2002 Apr;8(2):169-76.

PMID:
11990875
37.

Validation of Italian multiple sclerosis quality of life 54 questionnaire.

Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, Mantia LL, Farinotti M, Caputo D, Mosconi P.

J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):158-62.

38.

VR experience with neurological patients: basic cost/benefit issues.

Pugnetti L, Mendozzi L, Barbieri E, Motta A.

Stud Health Technol Inform. 1998;58:243-8. Review.

PMID:
10350925
39.

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients.

Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, Farinotti M, Eoli M, Mendozzi L.

Neurology. 1999 Jan 1;52(1):57-62.

PMID:
9921849
40.

Virtual environments in the diagnosis, prevention, and intervention of age-related diseases: a review of VR scenarios proposed in the EC VETERAN Project.

Riva G, Rizzo A, Alpini D, Attree EA, Barbieri E, Bertella L, Buckwalter JG, Davies RC, Gamberini L, Johansson G, Katz N, Marchi S, Mendozzi L, Molinari E, Pugnetti L, Rose FD, Weiss PL.

Cyberpsychol Behav. 1999;2(6):577-91. doi: 10.1089/cpb.1999.2.577.

PMID:
19178205
41.

Evaluation and retraining of adults' cognitive impairment: which role for virtual reality technology?

Pugnetti L, Mendozzi L, Motta A, Cattaneo A, Barbieri E, Brancotti A.

Comput Biol Med. 1995 Mar;25(2):213-27.

PMID:
7554839
42.

MRI and cognitive patterns in relapsing-remitting multiple sclerosis.

Pugnetti L, Mendozzi L, Motta A, Cattaneo A, Biserni P, Caputo D, Cazzullo CL, Valsecchi F.

J Neurol Sci. 1993 Apr;115 Suppl:S59-65.

PMID:
8340795
43.

Frontal lobe dysfunction in multiple sclerosis as assessed by means of Lurian tasks: effect of age at onset.

Mendozzi L, Pugnetti L, Saccani M, Motta A.

J Neurol Sci. 1993 Apr;115 Suppl:S42-50.

PMID:
8340792

Supplemental Content

Loading ...
Support Center